Screener
Fulgent Genetics, Inc. FLGT EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Fulgent Genetics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
FAQ
- What is Fulgent Genetics, Inc.'s EBITDA margin?
- Fulgent Genetics, Inc. (FLGT) reported EBITDA margin of -25.5% in Q1 2026.
- How has Fulgent Genetics, Inc.'s EBITDA margin changed year-over-year?
- Fulgent Genetics, Inc.'s EBITDA margin decreased by 56.3% year-over-year, from -16.3% to -25.5%.
- What is the long-term trend for Fulgent Genetics, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s EBITDA margin has grown at a -21.5% compound annual growth rate (CAGR), from 69.5% to -20.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Fulgent Genetics, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude